Table 1.
Stage of neoplasia | Sporadic human CRC | Human IBD-associated CRC | CTT colitis-CRC |
Normal-appearing mucosa | APC initiator | Inflammation leading to mutations listed below | No cell line mutations in APC exon 4 and 15[58] |
Early adenoma/indefinite dysplasia | Aneuploidy, methylation, Sialyl Tn | Aneuploidy, methylation, Sialyl Tn, MSI | 90%diploid; no methylation[59] |
Early promotor | MSI; kRAS, COX-2 | DCC | kRAS absent[60] |
Intermediate adenoma/low-grade dysplasia | c-src | c-src | c-src ND |
Intermediate promoter | DCC/DPC4 | kRAS | DCC/DPC4 ND; kRAS absent[60] |
Late promoter | p53 | APC | p53 ND; as above for APC exon 4 and 15[58] |
Adapted from Itzkowitz and Harpaz 2004[61]; and Mattar MC, Lough D, Pishvaian MJ, Charabaty A[62]. APC: Adenomatous polyposis coli gene; MSI: Microsatellite instability; DCC: Deleted in colon cancer; kRAS: V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; COX-2: Cyclooxygenase 2 gene; c-src: Rous sarcoma gene that encodes for usual C-terminal inhibitory phosphorylation site (tyrosine-527); DPC4: Deleted in pancreatic carcinoma, locus 4; p53: Protein 53 kilodaltons; ND: Not done.